Treatment of prosthetic valve thrombosis: Rationale for a prospective randomized clinical trial

Journal of Heart Valve Disease

Volumn 19, Issue 2, 2010, Pages 161-170

  Cevik, Cihan ^a   Izgi, Cemil ^b   Dechyapirom, Weeranun ^a   Nugent, Kenneth ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b Ozel Gaziosmanpasa Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOLYTIC AGENT; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADD ON THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; DATA BASE; FIBRINOLYTIC THERAPY; HEART VALVE REPLACEMENT; HUMAN; INTRACARDIAC THROMBOSIS; LOW DRUG DOSE; MORBIDITY; MORTALITY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHETIC VALVE THROMBOSIS; THROMBECTOMY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION; DEVICE REMOVAL; HEART VALVE PROSTHESIS; PATHOLOGY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

DEVICE REMOVAL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOLYTIC THERAPY; THROMBOSIS;

EID: 77952306418     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Cáceres-Lóriga FM, Pérez-López H, Santos-Gracia J, Morlans-Hernandez K. Prosthetic heart valve thrombosis: Pathogenesis, diagnosis and management. Int J Cardiol 2006;110:1-6 (Pubitemid 44251058)
2. Lengyel M. Diagnosis and treatment of left-sided prosthetic valve thrombosis. Expert Rev Cardiovasc Ther 2008;6:85-93
3. Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1-e142
4. Vahanian A, Baumgartner H, Bax J, et al. Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268
5. Lengyel M, Horstkotte D, Völler H, Mistiaen WP; Working Group Infection, Thrombosis, Embolism and Bleeding of the Society for Heart Valve Disease. Recommendations for the management of prosthetic valve thrombosis. J Heart Valve Dis 2005;14:567-575
6. Horstkotte D, Burckhardt D. Prosthetic valve thrombosis. J Heart Valve Dis 1995;4:141-153
7. Barbetseas J, Nagueh SF, Pitsavos C, Toutouzas PK, Quiñones MA, Zoghbi WA. Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: An evaluation of clinical, transthoracic and transesophageal echocardiographic parameters. J Am Coll Cardiol 1998;32:1410-1417
8. Luluaga IT, Carrera D, D'Oliveira J, et al. Successful thrombolytic therapy after acute tricuspid-valve obstruction. Lancet 1971;1:1067-1068
9. Deviri E, Sareli P, Wisenbaugh T, Cronje SL. Obstruction of mechanical heart valve prostheses: Clinical aspects and surgical management. J Am Coll Cardiol 1991;17:646-650
10. Bollag L, Attenhofer Jost CH, Vogt PR, et al. Symptomatic mechanical heart valve thrombosis: High morbidity and mortality despite successful treatment options. Swiss Med Wkly 2001;131:109-116
11. Roudaut R, Lafitte S, Roudaut MF, et al. Management of prosthetic heart valve obstruction: Fibrinolysis versus surgery. Early results and longterm follow-up in a single-centre study of 263 cases. Arch Cardiovasc Dis 2009;102:269-277
12. Ozkan M, Kaymaz C, Kirma C, et al. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: A study using serial transesophageal echocardiography. J Am Coll Cardiol 2000;35:1881-1889 (Pubitemid 30342871)
13. Tong AT, Roudaut R, Ozkan M, et al, Prosthetic Valve Thrombolysis - Role of Transesophageal Echocardiography (PRO-TEE) Registry Investigators. Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: Results of the international PRO-TEE registry. J Am Coll Cardiol 2004;43:77-84
14. Cáceres-Lóriga FM, Pérez-López H, Morlans-Hernández K, et al. Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients. J Thromb Thrombolysis 2006;21:185-190
15. Nagy A, Dénes M, Lengyel M. Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: A study of 62 events. J Heart Valve Dis 2009;18:268-275
16. Biteker M, Duran NE, Gunduz S, et al. Comparing different intravenous thrombolytic treatment regimens in patients with prosthetic heart valve thrombosis under the guidance of serial transesophageal echocardiography: A 15-year study in a single center (TROIA Trial). Circulation 2008;118:S932
17. Reddy NK, Padmanabhan TN, Singh S, et al. Thrombolysis in left-sided prosthetic valve occlusion: Immediate and follow-up results. Ann Thorac Surg 1994;58:462-470
18. Gupta D, Kothari SS, Bahl VK, et al. Thrombolytic therapy for prosthetic valve thrombosis: Short- and long-term results Am Heart J 2000;140:906-916
19. Laffort P, Roudaut R, Roques X, et al. Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude Medical prosthesis: A clinical and transesophageal echocardiographic study. J Am Coll Cardiol 2000;35:739-746
20. Laplace G, Lafitte S, Labèque JN, et al. Clinical significance of early thrombosis after prosthetic mitral valve replacement: A postoperative monocentric study of 680 patients. J Am Coll Cardiol 2004;43:1283-1290
21. Bemurat LR, Laffort PR, Deville CJ, Roques XG, Baudet EM, Roudaut RP. Management of nonobstructive thrombosis of prosthetic mitral valve in asymptomatic patients in the early postoperative period: A study in 20 patients. Echocardiography 1999;16:339-346
22. Butchart EG, Gohlke-Bärwolf C, Antunes MJ, et al, Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J 2005;26:2463-2471
23. Guler R, Kaymaz C, Ozdemir N, Ozkan M. Normal plasma D-dimer levels stand for high negative predictive value in patients with prosthetic valve thrombosis: A new screening marker. E-Abstract Book, European Society of Cardiology 2005 Congress (http://spo.escardio.org/abstractbook/presentation. aspx?id=23471, accessed 04.07.2009)
24. Gueret P, Vignon P, Fournier P, et al. Transesophageal echocardiography for the diagnosis and management of nonobstructive thrombosis of mechanical mitral valve prosthesis. Circulation 1995;91:103-110
25. Orsinelli DA, Pearson AC. Detection of prosthetic valve strands by transesophageal echocardiography: Clinical significance in patients with suspected cardiac source of embolism. J Am Coll Cardiol 1995;26:1713-1718
26. Laurent M, Lelong B, Verhoye JP, et al. Prolonged heparin and vitamin K antagonist regimen for early non-obstructive thrombosis of mechanical mitral valve prostheses. J Heart Valve Dis 2008;17:533-541
27. Lengyel M, Vegh G, Vandor L. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis. J Heart Valve Dis 1999;8:167-173 (Pubitemid 29166809)
28. Lengyel M, Vandor L. The role of thrombolysis in the management of left-sided prosthetic valve thrombosis: A study of 85 cases diagnosed by transesophageal echocardiography. J Heart Valve Dis 2001;10:636-649 (Pubitemid 32970378)
29. Lengyel M. Thrombolysis should be regarded as first-line therapy for prosthetic valve thrombosis in the absence of contraindications. J Am Coll Cardiol 2005;45:325; author reply 326
30. Lengyel M. Management of prosthetic valve thrombosis. J Heart Valve Dis 2004;13:329-334
31. Meurin P, Tabet JY, Weber H, Renaud N, Ben Driss A. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement. Circulation 2006;113:564-569 (Pubitemid 43754357)